• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[非典型抗精神病药物治疗精神分裂症患者的攻击和敌意行为]

[Atypical neuroleptics in the treatment of aggression and hostility in schizophrenic patients].

作者信息

Briken P, Nika E, Krausz M, Naber D

机构信息

Zentrum für psychosoziale Medizin, Psychiatrie und Psychotherapie, Universitätsklinikum Hamburg-Eppendorf, Germany.

出版信息

Fortschr Neurol Psychiatr. 2002 Mar;70(3):139-44. doi: 10.1055/s-2002-20501.

DOI:10.1055/s-2002-20501
PMID:11880946
Abstract

The treatment of aggressive symptoms in schizophrenic patients is a relevant clinical problem. We systematically review the efficacy of the different atypical neuroleptics on acute or persistent aggressive symptoms also regarding methodological problems. Currently typical neuroleptics are still first choice in treating acute aggressive symptoms, while risperidone and olanzapine could be alternatives. In persistent aggression clozapin shows the best specific results. Typical depot neuroleptics should be considered in cases when medication compliance is a problem.

摘要

精神分裂症患者攻击症状的治疗是一个相关的临床问题。我们系统地回顾了不同非典型抗精神病药物对急性或持续性攻击症状的疗效,也涉及方法学问题。目前,典型抗精神病药物仍是治疗急性攻击症状的首选,而利培酮和奥氮平可作为替代药物。在持续性攻击方面,氯氮平显示出最佳的特定疗效。当药物依从性存在问题时,应考虑使用典型长效抗精神病药物。

相似文献

1
[Atypical neuroleptics in the treatment of aggression and hostility in schizophrenic patients].[非典型抗精神病药物治疗精神分裂症患者的攻击和敌意行为]
Fortschr Neurol Psychiatr. 2002 Mar;70(3):139-44. doi: 10.1055/s-2002-20501.
2
The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia.非典型抗精神病药物治疗精神分裂症患者抑郁症状、敌意和自杀倾向的疗效。
J Clin Psychiatry. 2000;61 Suppl 3:4-9.
3
The role of typical and atypical antipsychotic medications in the management of agitation and aggression.典型和非典型抗精神病药物在激越与攻击行为管理中的作用。
J Clin Psychiatry. 1999;60 Suppl 10:52-60.
4
Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.氯氮平、奥氮平、利培酮及氟哌啶醇对精神分裂症患者敌意情绪的影响。
Psychiatr Serv. 2001 Nov;52(11):1510-4. doi: 10.1176/appi.ps.52.11.1510.
5
Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO).氯氮平、奥氮平、喹硫平、利培酮及氟哌啶醇单药治疗对精神分裂症门诊患者敌意和攻击行为的疗效:一项前瞻性自然主义研究(IC-SOHO)
Eur Psychiatry. 2005 Aug;20(5-6):403-8. doi: 10.1016/j.eurpsy.2005.01.009.
6
[New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation].[用于精神分裂症阴性症状的新型即非典型抗精神病药物:评估结果与方法学问题]
Nervenarzt. 2000 May;71(5):345-53. doi: 10.1007/s001150050568.
7
[Viewpoint of schizophrenic patients: a European survey].
Encephale. 2001 Jan-Feb;27(1):28-38.
8
Atypical neuroleptics in child and adolescent psychiatry.儿童及青少年精神病学中的非典型抗精神病药物。
Eur Child Adolesc Psychiatry. 2000;9 Suppl 1:I9-19. doi: 10.1007/s007870070015.
9
Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.糖尿病与使用非典型抗精神病药物治疗精神分裂症之间的关联。
Am J Psychiatry. 2002 Apr;159(4):561-6. doi: 10.1176/appi.ajp.159.4.561.
10
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.氯氮平、奥氮平、利培酮及氟哌啶醇治疗慢性精神分裂症和分裂情感性障碍患者
Am J Psychiatry. 2002 Feb;159(2):255-62. doi: 10.1176/appi.ajp.159.2.255.

引用本文的文献

1
Demographics, clinical characteristics, and treatment of aggressive patients admitted to the acute behavioral unit of a community general hospital: a prospective observational study.社区综合医院急性行为科收治的攻击性患者的人口统计学、临床特征及治疗:一项前瞻性观察研究。
Prim Care Companion CNS Disord. 2014;16(3). doi: 10.4088/PCC.13m01589. Epub 2014 Jun 5.
2
The neurobiological bases for development of pharmacological treatments of aggressive disorders.攻击性行为障碍药物治疗发展的神经生物学基础。
Curr Neuropharmacol. 2007;5(2):135-47. doi: 10.2174/157015907780866929.